Skip to main content
Advertisement

< Back to Article

Efficacy and Safety of Pafuramidine versus Pentamidine Maleate for Treatment of First Stage Sleeping Sickness in a Randomized, Comparator-Controlled, International Phase 3 Clinical Trial

Table 5

Secondary efficacy variables at months 3, 6, 12, 18, and 24 (per-protocol dataset).

Table 5

doi: https://doi.org/10.1371/journal.pntd.0004363.t005